NASDAQ:BDMD - Nasdaq - KYG0705H1039 - Common Stock - Currency: USD
TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 6.09M | 7.24M | 2.04M | 710.00K | N/A | |||
Selling, General, and Administrative Expenses | 6.09M | 7.24M | 2.04M | 710.00K | N/A | |||
Operating Income | -6.09M | -7.24M | -2.04M | -710.00K | 0.00 | |||
Interest Income/Expense | 1.49M | 4.94M | 3.29M | 10.00K | N/A | |||
Income Before Taxes | -4.60M | -2.30M | 1.24M | -700.00K | N/A | |||
Income Tax | 275.66K | 985.21K | 620.00K | N/A | N/A | |||
Net Income | -4.88M | -3.29M | 620.00K | -700.00K | N/A | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.74 | -0.35 | 0.02 | -0.02 | N/A | |||
Statistics |
All data in USD